US8563321B2 - Chemiluminescent compositions, enhancing reagents for chemiluminescence and methods for the preparation and use thereof - Google Patents

Chemiluminescent compositions, enhancing reagents for chemiluminescence and methods for the preparation and use thereof Download PDF

Info

Publication number
US8563321B2
US8563321B2 US13/177,189 US201113177189A US8563321B2 US 8563321 B2 US8563321 B2 US 8563321B2 US 201113177189 A US201113177189 A US 201113177189A US 8563321 B2 US8563321 B2 US 8563321B2
Authority
US
United States
Prior art keywords
alkyl
quaternary ammonium
ammonium salt
chemiluminescence
enhancing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US13/177,189
Other versions
US20120015446A1 (en
Inventor
Chungen QIAN
Yuping Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Mindray Bio Medical Electronics Co Ltd
Original Assignee
Shenzhen Mindray Bio Medical Electronics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Mindray Bio Medical Electronics Co Ltd filed Critical Shenzhen Mindray Bio Medical Electronics Co Ltd
Assigned to SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. reassignment SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: QIAN, CHUNGEN, ZHANG, YUPING
Publication of US20120015446A1 publication Critical patent/US20120015446A1/en
Priority to US14/051,151 priority Critical patent/US9139766B2/en
Application granted granted Critical
Publication of US8563321B2 publication Critical patent/US8563321B2/en
Assigned to Shenzhen Mindray Animal Medical Technology Co., Ltd. reassignment Shenzhen Mindray Animal Medical Technology Co., Ltd. LICENSE (SEE DOCUMENT FOR DETAILS). Assignors: SHENZHEN MINDRAY BIOMEDICAL ELECTRONICS CO., LTD.
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • C09K11/07Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials having chemically interreactive components, e.g. reactive chemiluminescent compositions
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances

Definitions

  • the present disclosure relates to the field of chemiluminescence immunoassays, particularly reagents and methods for enhancing the chemiluminescence of a 1,2-dioxetane compound, preparation methods and kits thereof, chemiluminescent compositions containing the enhancing reagents, and preparation methods and kits thereof.
  • FIG. 1 shows a plot of relative luminescence intensity vs. time for the chemiluminescent composition according to Example 15, wherein the X-axis is time and the Y-axis is relative luminescence intensity;
  • FIG. 2 is a comparison of luminescence signals of luminescent compositions with or without the enhancing reagent in Example 16, with a commercial luminescent composition control, wherein the X-axis is time and the Y-axis is relative luminescence intensity;
  • FIG. 3 is a comparison of luminescence signals of luminescent compositions with or without the enhancing reagent in Example 17, with a commercial luminescent composition control, wherein the X-axis is time and the Y-axis is relative luminescence intensity;
  • FIG. 4 is a comparison of luminescence signals of luminescent compositions with or without the enhancing reagent in Example 18, with a commercial luminescent composition control, wherein the X-axis is time and the Y-axis is relative luminescence intensity.
  • Chemiluminescence immunoassay As a non-radioactive immunoassay technology, chemiluminescence immunoassays developed very quickly in the world after enzyme immunoassay (EIA), radioimmunoassay, and fluorescence immunoassay technologies. Chemiluminescence immunoassay is a microassay technology which has high sensitivity, wide detection range, simple and fast operation, stable label, and low contamination, making it a desirable quantitative immunoassay method.
  • EIA enzyme immunoassay
  • radioimmunoassay radioimmunoassay
  • fluorescence immunoassay fluorescence immunoassay technologies.
  • Chemiluminescence immunoassay is a microassay technology which has high sensitivity, wide detection range, simple and fast operation, stable label, and low contamination, making it a desirable quantitative immunoassay method.
  • Luminol, isoluminol, acridine esters, and 1,2-dioxetane compounds are used as luminescent substances in chemiluminescence immunoassays. Isoluminol and acridine esters are labeled directly and act as tracing molecules in flash-type chemiluminescent reactions. However, Luminol and the 1,2-dioxetane compounds are activated by enzymes and act as tracing molecules after enzymatic catalysis in a glow-type chemiluminescent reaction.
  • the 1,2-dioxetane compounds are alkaline phosphatase (ALP) substrates with ultra-high sensitivity.
  • ALP When they contact ALP in appropriate buffers, ALP will hydrolyze them to provide strong optical signals which can be maintained over 20 hours. So, 1,2-dioxetane compounds are regarded as desirable chemiluminescent substances.
  • kits where ALP is the labeling enzyme and 1,2-dioxetane compounds are ALP's substrates were used in some automatic chemiluminescence systems, for example, developed by DPC, Beckman, BioMerieux, and Olympus.
  • 1,2-dioxetane compounds such as CSPD, CDP, CDP-Star, and BZPD and luminescent compositions thereof are patented and have good luminescence and high prices.
  • Another 1,2-dioxetane compound, 3-(2-spiroadamantane)-4-methoxy-4-(3-phosphoryloxy)phenyl-1,2-dioxetane (AMPPD) is widely known but the optical signal intensity is much weaker than that of the compounds above.
  • the molecular structure of AMPPD has a four-member heterocycle with a very weak —O—O— bond and a phosphate group, in which the phosphate group maintains the stability of the whole molecular structure. Normally, this compound is very stable, and is scarcely decomposed when stored at 5° C. as a solid. After catalysis by alkaline phosphatase, AMPPD is hydrolyzed at the phosphate group to form a labile intermediate. The intermediate automatically decomposes, with the four-member heterocycle with an —O—O— bond releasing a great deal of energy, thus exciting a chemiluminescent reaction, and emitting photons.
  • U.S. Pat. No. 5,145,772 discloses that poly(vinylbenzyldimethylbenzylammonium chloride) (BDMQ) and a macromolecular substance such as serum albumin can enhance luminescence of 1,2-dioxetane compounds.
  • U.S. Pat. No. 5,547,836 discloses that poly(vinylbenzyltrimethylammonium chloride) (TMQ) and poly(vinylbenzyltributylammonium chloride) (TBQ) are useful as enhancing reagents for luminescence of the 1,2-dioxetane compounds.
  • U.S. Pat. No. 5,393,469 discloses that polymeric quaternary phosphonium salt provides enhanced chemiluminescence from enzymatically triggered 1,2-dioxetane compounds.
  • U.S. Pat. No. 5,650,099 and Chinese Patent CN1208399A disclose that dual-cationic surfactants such as trioctylphosphinemethyl-4-tributylphosphinemethylphenyl dichloride, and fluorescent substances such as fluoroescein and hydroxypyrenesulfonic acid, provide enhanced luminescence from 1,2-dioxetane compounds.
  • dual-cationic surfactants such as trioctylphosphinemethyl-4-tributylphosphinemethylphenyl dichloride
  • fluorescent substances such as fluoroescein and hydroxypyrenesulfonic acid
  • Cidecylamino fluoroescein discloses a chemiluminescent composition including CSPD as substrate and enhancing reagents containing cetyltrimethylammonium chloride, myristoylglycerol phosphate disodium, bovine serum albumin, and octadecylamino fluoroescein.
  • enhancing reagents for enhancing luminescence of the 1,2-dioxetane compounds disclosed in the patents above are polymers and long-chain alkyl fluorescent substances, and they are expensive and not easily available.
  • this disclosure provides a new chemiluminescent composition, a new reagent and a method for enhancing the luminescence of 1,2-dioxetane compounds.
  • the present disclosure relates to enhancing reagents for enhancing chemiluminescence of 1,2-dioxetane compounds, and kits thereof, where the enhancing reagents or the kits contain at least an alkyl bis-quaternary ammonium salt having the structure of General Formula I:
  • R 1 is selected from at least one of the following: C 10-20 alkyl, C 10-20 alkenyl, C 10-20 alkynyl, and C 3-8 cycloalkylC 6-12 alkyl-; each n is an integer independently selected from 2 to 15, and each m is an integer independently selected from 1 to 6; R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 are each independently selected from at least one of the following: C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, and C 3-8 cycloalkyl; and X ⁇ is a negative ion.
  • the present disclosure relates to methods for preparing enhancing reagents for chemiluminescence of 1,2-dioxetanes, the methods comprising dissolving the components of the enhancing reagents of the present disclosure in water.
  • the present disclosure relates to methods for enhancing chemiluminescence of 1,2-dioxetanes, the methods comprising adding the enhancing reagents of the present disclosure to 1,2-dioxetane solutions, or using the kits of the present disclosure.
  • the present disclosure relates to chemiluminescent compositions and kits thereof, which contain 1,2-dioxetane compounds and the enhancing reagent of the present disclosure.
  • the present disclosure relates to the use of an alkyl bis-quaternary ammonium salt having a structure of General Formula I in preparing chemiluminescent compositions.
  • Chemiluminescent enhancing reagents of the present disclosure have simple components and desirable enhancing effects for 1,2-dioxetanes.
  • the chemiluminescent compositions of the present disclosure provide stable, long-lasting and greatly enhanced chemiluminescence signals and may be used in chemiluminescence immunoassays, DNA probe detection, and chemiluminescence analysis of biological membrane protein blotting.
  • the chemiluminescent compositions of the present disclosure may be widely used in the fields of clinical diagnosis, scientific research, environmental and hygiene detection, and forensic identification.
  • alkyl as used herein individually or in combination with other groups refers to straight or branched alkyl groups containing 1-18 carbon atoms, such as 1-12, 1-8, and 1-6 carbon atoms.
  • C 1-6 alkyl includes C 1-4 alkyl, C 1-3 alkyl, methyl, ethyl, n-propyl, isopropyl and tert-butyl. The same rules apply to other groups as used throughout the present specification.
  • alkenyl refers to a monovalent or divalent hydrocarbon chain having a carbon-carbon double bond, such as a monovalent, unsaturated group having a carbon-carbon double bond. Alkenyl groups may be cyclic, branched, or straight.
  • alkynyl refers to a monovalent or divalent unsaturated group containing a carbon-carbon triple bond. Alkynyl groups may be branched or straight.
  • cycloalkyl refers to a saturated monocyclic or bicyclic carbocyclic group, such as cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl.
  • aryl refers to an optionally substituted aromatic carbocyclic group, such as monocylic or bicylic groups having 6-12 carbon atoms in the ring moiety, for example, phenyl, biphenyl, naphthyl, substituted phenyl, substituted biphenyl, or substituted naphthyl.
  • Preferred aryl groups are phenyl or substituted phenyl.
  • halogen as used herein includes fluorine, chlorine, bromine, and iodine.
  • a soluble salt refers to a water soluble salt, and includes, but is not limited to, halide, sulfate, carbonate, and phosphate.
  • Chemiluminescence is light generated in a specific reaction of a chemical substance. Singlet molecules are excited and formed as high energy intermediates decompose in a chemical reaction, then the excited singlet molecules return to the ground state, and part of the energy is emitted in the form of luminescence. Therefore, chemiluminescent reactions include two processes: an excitation process and a luminescence process. Some molecular energy will also be dissipated in the excited state because of inter- and intra-system crossing.
  • 1,2-dioxetane compounds are chemiluminescent substrates, and their structures are well-known in the art.
  • a typical structure is as follows:
  • R 1 is selected from at least one of alkyl, aryl, aralkyl, alkaryl, heteroalkyl, heteroaryl, cycloalkyl, heterocycloalkyl, alkyloxyalkyl, alkyloxyaryl, alkyloxyhaloalkyl, alkylalkenyl, alkylalkynyl, halogenated alkyl, alkyl alcohol, alkyl carbonitrile, alkyl amine, alkyl acid, halogenated alkyl alcohol, halogenated alkyl carbonitrile, halogenated alkyl amine, and halogenated alkyl acid;
  • X is hydrogen or a substituent on a phenyl ring;
  • Y is hydrogen, alkyl, acetoxyl, t-butyldimethylsilyl, a group capable of being cleaved by an enzyme, or a group capable of being cleaved by an antibody; and Z is hydrogen or a substituent
  • 1,2-dioxetane compounds used herein include, but are not limited to, 3-(2′-spiroadamantane)-4-methoxy-4-(3′′-phosphoryloxy)phenyl-1,2-dioxetane (AMPPD), disodium 3-(4-methoxyspiro ⁇ 1,2-dioxetane-3,2′-(5′-chloro)tricyclo[3.3.1.13,7]decan ⁇ -4-yl)phenyl phosphate (CSPD), and disodium 2-chloro-5-(4-methoxyspiro ⁇ 1,2-dioxetane-3,2′-(5′-chloro)-tricyclo[3.3.1.13,7]decan ⁇ -4-yl)-1-phenyl phosphate (CDP-Star).
  • AMPPD 3-(2′-spiroadamantane)-4-methoxy-4-(3′′-phosphoryloxy)phenyl-1,2-dioxetane
  • AMPPD can be effectively decomposed by an alkaline phosphatase, by removal of a phosphate group to form an AMPPD intermediate.
  • the intermediate is cleaved into adamantanone and a meta-oxy methyl benzoate anion in the excited state through inter-molecular electron transfer.
  • the meta-wry methyl benzoate anion transitions from the excited state to the ground state, light with a maximal wavelength of 477 nm is generated.
  • Chemiluminescence from AMPPD catalyzed with an alkaline phosphatase can reach its peak at 15 min of reaction time, and then the optical signal strength remains relatively constant for between 15 to 60 min, with small variation. Chemiluminescence measurements may still be correct even after 12 h.
  • AMPPD is used in a range of 0.0001-0.01 mol/L.
  • 1,2-dioxetane compounds can be activated using different enzymes, for example, galactosidase, glucose oxidase, and catalase.
  • Y may be chemically cleaved, to activate the 1,2-dioxetane compounds to emit light.
  • chemiluminescence immunoassays it is expected that chemical bond energy is converted into light energy as efficiently as possible, and that the generated chemiluminescence signal intensity is high and stable.
  • the efficiency of the chemiluminescent reaction is dependent on the quantum efficiency of generating fluorescence and phosphorescence.
  • Methods for improving the chemiluminescence intensity include: improving the quantum yield of luminescent substrate molecules, improving the enzyme activity, and stabilizing the luminescent molecules in the excited state.
  • the present disclosure provides enhancing reagents for chemiluminescence of 1,2-dioxetanes, and kits thereof, in which the enhancing reagents or the kits contain at least an alkyl bis-quaternary ammonium salt having a structure of General Formula I:
  • R 1 is selected from at least one of the following: C 10-20 alkyl, C 10-20 alkenyl, C 10-20 alkynyl, and C 3-8 cycloalkylC 6-12 alkyl-; each n is an integer independently selected from 2 to 15, and each m is an integer independently selected from 1 to 6; R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 are each independently selected from at least one of the following: C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, and C 3-8 cycloalkyl; and X ⁇ is a negative ion.
  • the present disclosure provides enhancing reagents for chemiluminescence of 1,2-dioxetanes, which contain at least an alkyl bis-quaternary ammonium salt having a structure of General Formula II:
  • R is selected from C 10-20 alkyl; each n is an integer independently selected from 5-15; and X ⁇ is a negative ion.
  • R 1 is selected from C 12-18 alkyl, for example, R 1 may be selected from C 12 alkyl or C 18 alkyl.
  • R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 are alkyl, each having the same number of carbon atoms, or are each identical alkyl, or are each independently selected from methyl or ethyl, for example, where the groups are methyl.
  • each n is an integer independently selected from 5-10, for example, n may be 5 or 10.
  • each m is an integer independently selected from 2 or 3.
  • X ⁇ is selected from at least one of the following: halide ions, ClO 4 ⁇ , PF 6 ⁇ , CF 3 SO 3 ⁇ , BF 4 ⁇ , acetate, and p-toluene sulfonate anions.
  • R is selected from C 12-18 alkyl, for example, R may be selected from C 12 alkyl or C 18 alkyl.
  • the compound is selected from at least one of the following: Compound-1, Compound-2, Compound-3, and Compound-4:
  • the surfactants used in the embodiments of the present disclosure may form micelles in a solution, whose micro environment is non-aqueous. In the non-aqueous environment, the chemiluminescent reaction efficiency and quantum yield improve. Meanwhile, the surfactants may be conducive to the fluorescent molecules moving close to the chemiluminescent substrate molecules, allowing light energy transfer to occur once the chemiluminescence reaction starts. The quantum yield of the fluorescent molecules is much greater than that of the chemiluminescent molecules, thus enhancing the optical signal.
  • the alkyl bis-quaternary ammonium salt is generally used in an amount of 0.1 g/L to 10 g/L, for example, 1 g/L to 10 g/L.
  • the enhancing reagents according to the embodiments of the present disclosure may further include fluorescent agents, for example, fluorescein sodium, Rhodamine B, and Rhodamine 6G.
  • the fluorescent agents will emit another kind of fluorescence after receiving light energy from the luminescent substance.
  • the quantum yield of fluoroescein is far greater than that of the chemiluminescent substance, so the quantum yield of the luminescent substance may indirectly improve.
  • fluorescein sodium (9-(o-carboxyphenyl)-6-hydroxy-3H-xanthene-3-ketone disodium) is a water soluble fluorescent agent, and has an excitation and emission wavelength of 494 nm and 518 nm respectively.
  • the quantum yield of fluorescein sodium is up to 0.97.
  • Rhodamine series fluorescent agents also have a very high fluorescence quantum yield.
  • the fluorescent agent is used at concentration of about 0.1 mg/L to about 1 g/L.
  • the enhancing reagents of the present disclosure may further include optional magnesium ions, optional buffers, and optional preservatives, which have the same definitions as the corresponding components in chemiluminescent compositions below.
  • Components in the enhancing reagents above are dissolved in pure water, and water is added to a final volume, to prepare the enhancing reagents according to the embodiments of the present disclosure.
  • the enhancing reagents according to the embodiments of the present disclosure may be made into a kit by individually packaging the components of the enhancing reagent to form a multi-package system.
  • the components of the enhancing reagent may be combined according to need, and packaged in a mixture.
  • one package may contain two or more components, and the other packages may individually contain one or more other components.
  • the components may be mixed, and then packaged into a single mixture.
  • the components may be packaged in the form of solution, powder, or lyophilized powder.
  • the present disclosure further provides a method for enhancing luminescence of 1,2-dioxetane compounds, which includes adding the chemiluminescent enhancing reagents of the present disclosure into a solution containing 1,2-dioxetane compounds, or using the kit of the present disclosure.
  • the present disclosure further provides chemiluminescent compositions, which contain 1,2-dioxetane compounds and enhancing reagents of the present disclosure.
  • the chemiluminescent compositions of the present disclosure may further contain a buffer, for maintaining the pH of the reaction system.
  • the buffer includes a carbonate buffer, a diethanolamine buffer, 2-amino-2-methyl-1-propanol, and so on.
  • an appropriate buffer may be a 2-amino-2-methyl-1-propanol buffer system.
  • 2-amino-2-methyl-1-propanol may be a phosphate receptor in phosphotransfer, so as to improve the catalytic effect of ALP.
  • the alkaline phosphatase system the most suitable pH for the reaction may range from about 9 to about 10.
  • the buffer may be used at an amount of about 10 to about 500 mM.
  • the chemiluminescent compositions of the present disclosure may further contain magnesium ions, which are from soluble salts containing magnesium ions, for example, magnesium sulfate, magnesium acetate, magnesium chloride, and other salts from which magnesium ions can be dissociated in solution.
  • magnesium ions which are from soluble salts containing magnesium ions, for example, magnesium sulfate, magnesium acetate, magnesium chloride, and other salts from which magnesium ions can be dissociated in solution.
  • magnesium ions are from soluble salts containing magnesium ions, for example, magnesium sulfate, magnesium acetate, magnesium chloride, and other salts from which magnesium ions can be dissociated in solution.
  • the enhancing reagents of the present disclosure may further include a preservative, which facilitates the preservation and long-term storage of the reagent.
  • a preservative which facilitates the preservation and long-term storage of the reagent.
  • the preservatives may be used at any concentration which will not influence the chemiluminescent reaction and the activity of alkaline phosphatase.
  • the chemiluminescent substrate such as a 1,2-dioxetane compound
  • the enhancing reagent of the present disclosure are mixed and dissolved.
  • a buffer component, magnesium ions, or a preservative may be added.
  • the pH of the chemiluminescent composition may be adjusted. For example, if the substrate in the chemiluminescent composition is activated by an alkaline phosphatase, the pH of the enhancing reagent may be adjusted to about 9 to about 10.
  • the chemiluminescent compositions of the present disclosure may be made into a kit by individually packaging the components of the chemiluminescent composition, or by mixing some of components in one container, while the others are stored in separate containers. Alternatively, the components of the chemiluminescent composition may be formulated as a single mixture. According to different detection uses, the kit may further include corresponding enzyme reagents, labeled enzyme reagent, a solid-phase antibody or a manual which instructs the operator.
  • the present disclosure provides for use of an alkyl bis-quaternary ammonium salt having the structure of General Formula I in preparation of a chemiluminescent composition or enhancing reagent for chemiluminescence using 1,2-dioxetane compounds.
  • the alkyl bis-quaternary ammonium salts of the present disclosure have good chemiluminescent enhancing effects with substances such as 1,2-dioxetane compounds.
  • most of these salts are commercially available, inexpensive, and suitable for production of chemiluminescent compositions on a large scale.
  • chemiluminescence analyzer is a BHP9507 chemiluminescence analyzer supplied from Beijing Hamamatsu Photon Techniques Inc.
  • a basic luminescent composition was formulated with ultra-pure water as follows:
  • chemiluminescent composition 100 ⁇ l of the chemiluminescent composition from each example was added to 50 ⁇ l of a 1 ng/mL solution of alkaline phosphatase.
  • Chemiluminescence intensity (RLU) was measured by a chemiluminescence analyzer and the fold increase in RLU was calculated for each chemiluminescent composition versus the basic luminescent composition.
  • RLU Chemiluminescence intensity
  • examples 2 to 8 of Table 1 the alkyl bis-quaternary ammonium salt used alone enhances chemiluminescence from the chemiluminescent composition; the effect was similar to that of the fluorescent agent used alone.
  • Examples 9 to 14 of Table 1 also show that the alkyl bis-quaternary ammonium salt and the fluorescent agent act synergistically, significantly enhancing the luminescence signal of AMPPD.
  • a chemiluminescent composition was prepared as follows:
  • chemiluminescent composition 100 ⁇ l of the chemiluminescent composition was added to 50 ⁇ l of a 1 ng/mL solution of alkaline phosphatase. Chemiluminescence intensity was measured by a chemiluminescence analyzer, and a chemiluminescent intensity-time curve was plotted. The results are shown in FIG. 1 , which demonstrates that the luminescence signal of the chemiluminescent composition of the present disclosure is stable and long lasting.
  • chemiluminescent composition was formulated with ultra-pure water as follows:
  • chemiluminescent composition 100 ⁇ l of the chemiluminescent composition was added to 20 ⁇ l of a 1 ng/mL solution of alkaline phosphatase. Chemiluminescence intensity was measured by a chemiluminescence analyzer. A commercial chemiluminescent composition, Access Substrate (Beckman), was also measured as a control for comparison. The results are shown in FIG. 2 , which demonstrates that the enhancing reagent of the present disclosure enhances the luminescence signal of AMPPD, and that the performance of the chemiluminescent composition is similar to that of Access Substrate (Beckman).
  • a chemiluminescent composition was prepared with ultra-pure water as follows:
  • chemiluminescent composition 100 ⁇ l of the chemiluminescent composition was added to 20 ⁇ l of a 1 ng/mL solution of alkaline phosphatase. Chemiluminescence intensity was measured by a chemiluminescence analyzer. A commercial chemiluminescent composition, CSPD & Sapphire-II (Tropix), was also measured as a control for comparison. The results are shown in FIG. 3 , which demonstrates that the enhancing reagent of the present disclosure enhances the luminescence signal of CSPD, and that the performance of the chemiluminescent composition is similar to that of CSPD & Sapphire-II (Tropix).
  • a chemiluminescent composition was prepared with ultra-pure water as follows:
  • chemiluminescent composition 100 ⁇ l of the chemiluminescent composition was added to 20 ⁇ l of a 1 ng/mL solution of alkaline phosphatase. Chemiluminescence intensity was measured by a chemiluminescence analyzer. A commercial chemiluminescent composition, CSPD & Sapphire-II (Tropix), was also measured as a control for comparison. The results are shown in FIG. 4 , which demonstrates that the enhancing reagent of the present disclosure enhances the luminescence signal of CDP-Star, and that the performance of the chemiluminescent composition is similar to that of CSPD & Sapphire-II (Tropix).
  • alkyl bis-quaternary ammonium salts demonstrate good chemiluminescent enhancing effects for 1,2-dioxetane compounds, as well as an unexpected synergistic enhancing effects in combination with fluorescent agents.
  • Chemiluminescent compositions containing alkyl bis-quaternary ammonium salts can generate strong luminescence signals, thereby improving the detection sensitivity of a diagnosis kit.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A enhancing reagent for enhancing chemiluminescence of 1,2-dioxetane compounds and a method for using the enhancing reagent to enhance the chemiluminescence are provided, in which the enhancing reagent contains an alkyl bis-quaternary ammonium salt of Formula I. A chemiluminescent composition with a 1,2-dioxetane compound as a substrate and a kit thereof are further provided, which contain a 1,2-dioxetane compound and an alkyl bis-quaternary ammonium salt of Formula I.
Figure US08563321-20131022-C00001

Description

RELATED APPLICATIONS
This application claims priority to Chinese Patent Application No. 201010226676.4, filed Jul. 13, 2010, for “ENHANCING REAGENT FOR CHEMILUMINESCENCE, PREPARATION METHOD THEREOF, AND CHEMILUMINESCENT COMPOSITION,” the disclosure of which is fully incorporated herein by reference.
FIELD OF DISCLOSURE
The present disclosure relates to the field of chemiluminescence immunoassays, particularly reagents and methods for enhancing the chemiluminescence of a 1,2-dioxetane compound, preparation methods and kits thereof, chemiluminescent compositions containing the enhancing reagents, and preparation methods and kits thereof.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows a plot of relative luminescence intensity vs. time for the chemiluminescent composition according to Example 15, wherein the X-axis is time and the Y-axis is relative luminescence intensity;
FIG. 2 is a comparison of luminescence signals of luminescent compositions with or without the enhancing reagent in Example 16, with a commercial luminescent composition control, wherein the X-axis is time and the Y-axis is relative luminescence intensity;
FIG. 3 is a comparison of luminescence signals of luminescent compositions with or without the enhancing reagent in Example 17, with a commercial luminescent composition control, wherein the X-axis is time and the Y-axis is relative luminescence intensity; and
FIG. 4 is a comparison of luminescence signals of luminescent compositions with or without the enhancing reagent in Example 18, with a commercial luminescent composition control, wherein the X-axis is time and the Y-axis is relative luminescence intensity.
DETAILED DESCRIPTION OF THE DISCLOSURE
As a non-radioactive immunoassay technology, chemiluminescence immunoassays developed very quickly in the world after enzyme immunoassay (EIA), radioimmunoassay, and fluorescence immunoassay technologies. Chemiluminescence immunoassay is a microassay technology which has high sensitivity, wide detection range, simple and fast operation, stable label, and low contamination, making it a desirable quantitative immunoassay method.
Luminol, isoluminol, acridine esters, and 1,2-dioxetane compounds are used as luminescent substances in chemiluminescence immunoassays. Isoluminol and acridine esters are labeled directly and act as tracing molecules in flash-type chemiluminescent reactions. However, Luminol and the 1,2-dioxetane compounds are activated by enzymes and act as tracing molecules after enzymatic catalysis in a glow-type chemiluminescent reaction. The 1,2-dioxetane compounds are alkaline phosphatase (ALP) substrates with ultra-high sensitivity. When they contact ALP in appropriate buffers, ALP will hydrolyze them to provide strong optical signals which can be maintained over 20 hours. So, 1,2-dioxetane compounds are regarded as desirable chemiluminescent substances. Several manufacturers have developed kits where ALP is the labeling enzyme and 1,2-dioxetane compounds are ALP's substrates. These kits were used in some automatic chemiluminescence systems, for example, developed by DPC, Beckman, BioMerieux, and Olympus.
Some 1,2-dioxetane compounds such as CSPD, CDP, CDP-Star, and BZPD and luminescent compositions thereof are patented and have good luminescence and high prices. Another 1,2-dioxetane compound, 3-(2-spiroadamantane)-4-methoxy-4-(3-phosphoryloxy)phenyl-1,2-dioxetane (AMPPD), is widely known but the optical signal intensity is much weaker than that of the compounds above.
The molecular structure of AMPPD has a four-member heterocycle with a very weak —O—O— bond and a phosphate group, in which the phosphate group maintains the stability of the whole molecular structure. Normally, this compound is very stable, and is scarcely decomposed when stored at 5° C. as a solid. After catalysis by alkaline phosphatase, AMPPD is hydrolyzed at the phosphate group to form a labile intermediate. The intermediate automatically decomposes, with the four-member heterocycle with an —O—O— bond releasing a great deal of energy, thus exciting a chemiluminescent reaction, and emitting photons.
In 1989, Schaap reported a technology for enhancing the chemiluminescence of 1,2-dioxetane compounds using cetyltrimethylammonium bromide and 5-(N-tetradecanoyl)-aminofluoroescein (Clin. Chem., 35). In U.S. Pat. No. 4,959,182 and U.S. Pat. No. 5,004,565, and Chinese Patent CN89106249.1, Schaap describes methods for enhancing chemical and enzymatic triggered chemiluminescence of 1,2-dioxetane compounds by forming a micelle using cetyltrimethylammonium bromide.
U.S. Pat. No. 5,145,772 discloses that poly(vinylbenzyldimethylbenzylammonium chloride) (BDMQ) and a macromolecular substance such as serum albumin can enhance luminescence of 1,2-dioxetane compounds. U.S. Pat. No. 5,547,836 discloses that poly(vinylbenzyltrimethylammonium chloride) (TMQ) and poly(vinylbenzyltributylammonium chloride) (TBQ) are useful as enhancing reagents for luminescence of the 1,2-dioxetane compounds.
U.S. Pat. No. 5,393,469 discloses that polymeric quaternary phosphonium salt provides enhanced chemiluminescence from enzymatically triggered 1,2-dioxetane compounds.
U.S. Pat. No. 5,650,099 and Chinese Patent CN1208399A disclose that dual-cationic surfactants such as trioctylphosphinemethyl-4-tributylphosphinemethylphenyl dichloride, and fluorescent substances such as fluoroescein and hydroxypyrenesulfonic acid, provide enhanced luminescence from 1,2-dioxetane compounds.
Chinese Patent CN1719254A discloses a chemiluminescent composition including CSPD as substrate and enhancing reagents containing cetyltrimethylammonium chloride, myristoylglycerol phosphate disodium, bovine serum albumin, and octadecylamino fluoroescein.
Most of the enhancing reagents for enhancing luminescence of the 1,2-dioxetane compounds disclosed in the patents above are polymers and long-chain alkyl fluorescent substances, and they are expensive and not easily available.
Therefore, this disclosure provides a new chemiluminescent composition, a new reagent and a method for enhancing the luminescence of 1,2-dioxetane compounds.
The present disclosure relates to enhancing reagents for enhancing chemiluminescence of 1,2-dioxetane compounds, and kits thereof, where the enhancing reagents or the kits contain at least an alkyl bis-quaternary ammonium salt having the structure of General Formula I:
Figure US08563321-20131022-C00002
wherein, R1 is selected from at least one of the following: C10-20 alkyl, C10-20 alkenyl, C10-20 alkynyl, and C3-8 cycloalkylC6-12 alkyl-; each n is an integer independently selected from 2 to 15, and each m is an integer independently selected from 1 to 6; R2, R3, R4, R5, R6, and R7 are each independently selected from at least one of the following: C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, and C3-8 cycloalkyl; and X is a negative ion.
In a second aspect, the present disclosure relates to methods for preparing enhancing reagents for chemiluminescence of 1,2-dioxetanes, the methods comprising dissolving the components of the enhancing reagents of the present disclosure in water.
In a third aspect, the present disclosure relates to methods for enhancing chemiluminescence of 1,2-dioxetanes, the methods comprising adding the enhancing reagents of the present disclosure to 1,2-dioxetane solutions, or using the kits of the present disclosure.
In a fourth aspect, the present disclosure relates to chemiluminescent compositions and kits thereof, which contain 1,2-dioxetane compounds and the enhancing reagent of the present disclosure.
In a fifth aspect, the present disclosure relates to the use of an alkyl bis-quaternary ammonium salt having a structure of General Formula I in preparing chemiluminescent compositions.
Chemiluminescent enhancing reagents of the present disclosure have simple components and desirable enhancing effects for 1,2-dioxetanes. The chemiluminescent compositions of the present disclosure provide stable, long-lasting and greatly enhanced chemiluminescence signals and may be used in chemiluminescence immunoassays, DNA probe detection, and chemiluminescence analysis of biological membrane protein blotting. The chemiluminescent compositions of the present disclosure may be widely used in the fields of clinical diagnosis, scientific research, environmental and hygiene detection, and forensic identification.
In order to make other aspects and advantages of the present disclosure more apparent, the present disclosure is illustrated with reference to the following description and specific embodiments.
DEFINITIONS
Unless indicated otherwise, terms used herein have the following meanings.
The term “alkyl” as used herein individually or in combination with other groups refers to straight or branched alkyl groups containing 1-18 carbon atoms, such as 1-12, 1-8, and 1-6 carbon atoms. Reference to a single straight alkyl such as “n-propyl” specifically means a straight alkyl group, while reference to a single branched alkyl such as “isopropyl” specifically means a branched alkyl group. For example, “C1-6alkyl” includes C1-4alkyl, C1-3alkyl, methyl, ethyl, n-propyl, isopropyl and tert-butyl. The same rules apply to other groups as used throughout the present specification.
The term “alkenyl” refers to a monovalent or divalent hydrocarbon chain having a carbon-carbon double bond, such as a monovalent, unsaturated group having a carbon-carbon double bond. Alkenyl groups may be cyclic, branched, or straight.
The term “alkynyl” refers to a monovalent or divalent unsaturated group containing a carbon-carbon triple bond. Alkynyl groups may be branched or straight.
The term “cycloalkyl” refers to a saturated monocyclic or bicyclic carbocyclic group, such as cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl.
The term “aryl” as used herein refers to an optionally substituted aromatic carbocyclic group, such as monocylic or bicylic groups having 6-12 carbon atoms in the ring moiety, for example, phenyl, biphenyl, naphthyl, substituted phenyl, substituted biphenyl, or substituted naphthyl. Preferred aryl groups are phenyl or substituted phenyl.
The term “halogen” as used herein includes fluorine, chlorine, bromine, and iodine.
The term “a soluble salt” as used herein refers to a water soluble salt, and includes, but is not limited to, halide, sulfate, carbonate, and phosphate.
Enhancing Reagent for Chemiluminescence
Chemiluminescence is light generated in a specific reaction of a chemical substance. Singlet molecules are excited and formed as high energy intermediates decompose in a chemical reaction, then the excited singlet molecules return to the ground state, and part of the energy is emitted in the form of luminescence. Therefore, chemiluminescent reactions include two processes: an excitation process and a luminescence process. Some molecular energy will also be dissipated in the excited state because of inter- and intra-system crossing.
The 1,2-dioxetane compounds are chemiluminescent substrates, and their structures are well-known in the art. A typical structure is as follows:
Figure US08563321-20131022-C00003
wherein R1 is selected from at least one of alkyl, aryl, aralkyl, alkaryl, heteroalkyl, heteroaryl, cycloalkyl, heterocycloalkyl, alkyloxyalkyl, alkyloxyaryl, alkyloxyhaloalkyl, alkylalkenyl, alkylalkynyl, halogenated alkyl, alkyl alcohol, alkyl carbonitrile, alkyl amine, alkyl acid, halogenated alkyl alcohol, halogenated alkyl carbonitrile, halogenated alkyl amine, and halogenated alkyl acid; X is hydrogen or a substituent on a phenyl ring; Y is hydrogen, alkyl, acetoxyl, t-butyldimethylsilyl, a group capable of being cleaved by an enzyme, or a group capable of being cleaved by an antibody; and Z is hydrogen or a substituent on an adamantane ring.
The 1,2-dioxetane compounds used herein include, but are not limited to, 3-(2′-spiroadamantane)-4-methoxy-4-(3″-phosphoryloxy)phenyl-1,2-dioxetane (AMPPD), disodium 3-(4-methoxyspiro{1,2-dioxetane-3,2′-(5′-chloro)tricyclo[3.3.1.13,7]decan}-4-yl)phenyl phosphate (CSPD), and disodium 2-chloro-5-(4-methoxyspiro{1,2-dioxetane-3,2′-(5′-chloro)-tricyclo[3.3.1.13,7]decan}-4-yl)-1-phenyl phosphate (CDP-Star).
AMPPD can be effectively decomposed by an alkaline phosphatase, by removal of a phosphate group to form an AMPPD intermediate. The intermediate is cleaved into adamantanone and a meta-oxy methyl benzoate anion in the excited state through inter-molecular electron transfer. When the meta-wry methyl benzoate anion transitions from the excited state to the ground state, light with a maximal wavelength of 477 nm is generated. Chemiluminescence from AMPPD catalyzed with an alkaline phosphatase can reach its peak at 15 min of reaction time, and then the optical signal strength remains relatively constant for between 15 to 60 min, with small variation. Chemiluminescence measurements may still be correct even after 12 h. AMPPD is used in a range of 0.0001-0.01 mol/L.
A person of skill in the art can understand that, based on different cleavable groups, 1,2-dioxetane compounds can be activated using different enzymes, for example, galactosidase, glucose oxidase, and catalase. In addition, Y may be chemically cleaved, to activate the 1,2-dioxetane compounds to emit light.
In chemiluminescence immunoassays, it is expected that chemical bond energy is converted into light energy as efficiently as possible, and that the generated chemiluminescence signal intensity is high and stable. The efficiency of the chemiluminescent reaction is dependent on the quantum efficiency of generating fluorescence and phosphorescence. Methods for improving the chemiluminescence intensity include: improving the quantum yield of luminescent substrate molecules, improving the enzyme activity, and stabilizing the luminescent molecules in the excited state.
In one aspect, the present disclosure provides enhancing reagents for chemiluminescence of 1,2-dioxetanes, and kits thereof, in which the enhancing reagents or the kits contain at least an alkyl bis-quaternary ammonium salt having a structure of General Formula I:
Figure US08563321-20131022-C00004
wherein, R1 is selected from at least one of the following: C10-20 alkyl, C10-20 alkenyl, C10-20 alkynyl, and C3-8 cycloalkylC6-12 alkyl-; each n is an integer independently selected from 2 to 15, and each m is an integer independently selected from 1 to 6; R2, R3, R4, R5, R6, and R7 are each independently selected from at least one of the following: C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, and C3-8 cycloalkyl; and X is a negative ion.
In another aspect, the present disclosure provides enhancing reagents for chemiluminescence of 1,2-dioxetanes, which contain at least an alkyl bis-quaternary ammonium salt having a structure of General Formula II:
Figure US08563321-20131022-C00005
wherein R is selected from C10-20 alkyl; each n is an integer independently selected from 5-15; and X is a negative ion.
In one embodiment, R1 is selected from C12-18 alkyl, for example, R1 may be selected from C12 alkyl or C18 alkyl.
In one embodiment, R2, R3, R4, R5, R6, and R7 are alkyl, each having the same number of carbon atoms, or are each identical alkyl, or are each independently selected from methyl or ethyl, for example, where the groups are methyl.
In one embodiment, each n is an integer independently selected from 5-10, for example, n may be 5 or 10.
In one embodiment, each m is an integer independently selected from 2 or 3.
In one embodiment, X is selected from at least one of the following: halide ions, ClO4 , PF6 , CF3SO3 , BF4 , acetate, and p-toluene sulfonate anions.
In one embodiment, R is selected from C12-18 alkyl, for example, R may be selected from C12 alkyl or C18 alkyl.
In one embodiment, the compound is selected from at least one of the following: Compound-1, Compound-2, Compound-3, and Compound-4:
Figure US08563321-20131022-C00006
While not being bound by theory, it is believed that the surfactants used in the embodiments of the present disclosure may form micelles in a solution, whose micro environment is non-aqueous. In the non-aqueous environment, the chemiluminescent reaction efficiency and quantum yield improve. Meanwhile, the surfactants may be conducive to the fluorescent molecules moving close to the chemiluminescent substrate molecules, allowing light energy transfer to occur once the chemiluminescence reaction starts. The quantum yield of the fluorescent molecules is much greater than that of the chemiluminescent molecules, thus enhancing the optical signal. The alkyl bis-quaternary ammonium salt is generally used in an amount of 0.1 g/L to 10 g/L, for example, 1 g/L to 10 g/L.
The enhancing reagents according to the embodiments of the present disclosure may further include fluorescent agents, for example, fluorescein sodium, Rhodamine B, and Rhodamine 6G. The fluorescent agents will emit another kind of fluorescence after receiving light energy from the luminescent substance. The quantum yield of fluoroescein is far greater than that of the chemiluminescent substance, so the quantum yield of the luminescent substance may indirectly improve. For example, fluorescein sodium (9-(o-carboxyphenyl)-6-hydroxy-3H-xanthene-3-ketone disodium) is a water soluble fluorescent agent, and has an excitation and emission wavelength of 494 nm and 518 nm respectively. The quantum yield of fluorescein sodium is up to 0.97. Similarly, Rhodamine series fluorescent agents also have a very high fluorescence quantum yield. The fluorescent agent is used at concentration of about 0.1 mg/L to about 1 g/L.
Optionally, the enhancing reagents of the present disclosure may further include optional magnesium ions, optional buffers, and optional preservatives, which have the same definitions as the corresponding components in chemiluminescent compositions below.
Components in the enhancing reagents above are dissolved in pure water, and water is added to a final volume, to prepare the enhancing reagents according to the embodiments of the present disclosure.
The enhancing reagents according to the embodiments of the present disclosure may be made into a kit by individually packaging the components of the enhancing reagent to form a multi-package system. Alternatively, the components of the enhancing reagent may be combined according to need, and packaged in a mixture. For example, one package may contain two or more components, and the other packages may individually contain one or more other components. Alternatively, the components may be mixed, and then packaged into a single mixture. The components may be packaged in the form of solution, powder, or lyophilized powder.
Method for Enhancing Chemiluminescence
The present disclosure further provides a method for enhancing luminescence of 1,2-dioxetane compounds, which includes adding the chemiluminescent enhancing reagents of the present disclosure into a solution containing 1,2-dioxetane compounds, or using the kit of the present disclosure.
Chemiluminescent Compositions, and Preparation Method and Kits Thereof
The present disclosure further provides chemiluminescent compositions, which contain 1,2-dioxetane compounds and enhancing reagents of the present disclosure.
The chemiluminescent compositions of the present disclosure may further contain a buffer, for maintaining the pH of the reaction system. The buffer includes a carbonate buffer, a diethanolamine buffer, 2-amino-2-methyl-1-propanol, and so on. When luminescence of a chemiluminescent substance is triggered by cleavage of the phosphate group, an appropriate buffer may be a 2-amino-2-methyl-1-propanol buffer system. For example, in a reaction process where phosphate groups are cleaved by catalysis of alkaline phosphatase, 2-amino-2-methyl-1-propanol may be a phosphate receptor in phosphotransfer, so as to improve the catalytic effect of ALP. As for the alkaline phosphatase system, the most suitable pH for the reaction may range from about 9 to about 10. The buffer may be used at an amount of about 10 to about 500 mM.
The chemiluminescent compositions of the present disclosure may further contain magnesium ions, which are from soluble salts containing magnesium ions, for example, magnesium sulfate, magnesium acetate, magnesium chloride, and other salts from which magnesium ions can be dissociated in solution. When a 1,2-dioxetane compound containing a phosphate group is used as a chemiluminescent substrate, the phosphate group can be hydrolyzed by alkaline phosphatase, thus producing chemiluminescence. In this case, the addition of magnesium ions can activate alkaline phosphatase, thereby improving the catalytic performance of alkaline phosphatase for the hydrolysis reaction. The magnesium ions are used at a concentration range from about 0.001 to about 0.01 mol/L.
The enhancing reagents of the present disclosure may further include a preservative, which facilitates the preservation and long-term storage of the reagent. There is no limitation to the type of the preservative, and commercially available preservatives such as Proclin300, sodium azide, Kathon, and Gentamicin may be used. The preservatives may be used at any concentration which will not influence the chemiluminescent reaction and the activity of alkaline phosphatase.
To obtain the chemiluminescent composition of the present disclosure, the chemiluminescent substrate, such as a 1,2-dioxetane compound, and the enhancing reagent of the present disclosure are mixed and dissolved. Optionally, a buffer component, magnesium ions, or a preservative may be added. According to the conditions required for activating the substrate, the pH of the chemiluminescent composition may be adjusted. For example, if the substrate in the chemiluminescent composition is activated by an alkaline phosphatase, the pH of the enhancing reagent may be adjusted to about 9 to about 10.
The chemiluminescent compositions of the present disclosure may be made into a kit by individually packaging the components of the chemiluminescent composition, or by mixing some of components in one container, while the others are stored in separate containers. Alternatively, the components of the chemiluminescent composition may be formulated as a single mixture. According to different detection uses, the kit may further include corresponding enzyme reagents, labeled enzyme reagent, a solid-phase antibody or a manual which instructs the operator.
Use of Alkyl Bis-Quaternary Ammonium Salt Having a Structure of Formula I in Preparation of Chemiluminescent Compositions or Enhancing Reagents for Chemiluminescence of 1,2-Dioxetane Compounds
The present disclosure provides for use of an alkyl bis-quaternary ammonium salt having the structure of General Formula I in preparation of a chemiluminescent composition or enhancing reagent for chemiluminescence using 1,2-dioxetane compounds. The alkyl bis-quaternary ammonium salts of the present disclosure have good chemiluminescent enhancing effects with substances such as 1,2-dioxetane compounds. Moreover, most of these salts are commercially available, inexpensive, and suitable for production of chemiluminescent compositions on a large scale.
EXAMPLES
The present disclosure will be further described with references to the following particular examples. These examples are intended only to be illustrative, but not to limit the scope of the present disclosure in any sense.
Unless otherwise indicated, all of chemical reagents used in the examples were analytic pure, and supplied from Sigma-Aldrich Company. The chemiluminescence analyzer is a BHP9507 chemiluminescence analyzer supplied from Beijing Hamamatsu Photon Techniques Inc.
Examples 1 to 14
A basic luminescent composition was formulated with ultra-pure water as follows:
2-amino-2-methyl-1-propanol 200 mM
AMPPD 0.5 mM
MgCl
2 5 mM
Proclin300 0.5 g/L
pH was adjusted with HCl to 9.5
Appropriate amounts of components other than AMPPD were weighed, dissolved into ultra-pure water, pH adjusted, and adjusted to final volume with water. AMPPD was then added and dissolved, to obtain the basic luminescent composition in which the final concentrations of the components were as shown in the table above. Components of the respective enhancing reagent were added to the basic luminescent composition to formulate the chemiluminescent compositions of Example 1-14 (see Table 1).
100 μl of the chemiluminescent composition from each example was added to 50 μl of a 1 ng/mL solution of alkaline phosphatase. Chemiluminescence intensity (RLU) was measured by a chemiluminescence analyzer and the fold increase in RLU was calculated for each chemiluminescent composition versus the basic luminescent composition. As shown in examples 2 to 8 of Table 1, the alkyl bis-quaternary ammonium salt used alone enhances chemiluminescence from the chemiluminescent composition; the effect was similar to that of the fluorescent agent used alone. Examples 9 to 14 of Table 1 also show that the alkyl bis-quaternary ammonium salt and the fluorescent agent act synergistically, significantly enhancing the luminescence signal of AMPPD.
TABLE 1
Chemiluminescent compositions of Examples 1-14 and
intensity duration of chemiluminescence from AMPPD
Lumines-
cence Fold
Enhancing component(s) added to basic intensity Increase
Example luminescent composition (RLU) in RLU
1 No 7070 1.0
2 5 mg/L fluorescein Sodium 53025 7.5
3 1 mg/L Rhodamine 6G 36764 5.2
4 10 g/L Compound-1 (dodecylamino 38178 5.4
polyoxyethylene ether ammonium
dichloride)
5 1 g/L Compound-1 (dodecylamino 24038 3.4
polyoxyethylene ether ammonium
dichloride)
6 0.1 g/L Compound-1 (dodecylamino 14847 2.1
polyoxyethylene ether ammonium
dichloride)
7 1 g/L Compound-2 (octadecylamino 16968 2.4
polyoxyethylene ether ammonium
dichloride)
8 1 g/L Compound-4 (octadecylamino 12726 1.8
polyoxyethylene ether ammonium
dibromide)
9 5 g/L Compound-1 (dodecylamino 1204728 170.4
polyoxyethylene ether ammonium
dichloride), 5 mg/L fluorescein sodium
10 10 g/L Compound-1 (dodecylamino 1169378 165.4
polyoxyethylene ether ammonium
dichloride), 5 mg/L fluorescein sodium
11 0.1 g/L Compound-1 (dodecylamino 873145 123.5
polyoxyethylene ether ammonium
dichloride), 5 mg/L Rhodamine 6G
12 10 g/L Compound-1 (dodecylamino 1063328 150.4
polyoxyethylene ether ammonium
dichloride), 5 mg/L Rhodamine 6G
13 5 g/L Compound-2 (octadecylamino 674478 95.4
polyoxyethylene ether ammonium
dichloride), 5 mg/L fluorescein sodium
14 5 g/L Compound-4 (octadecylamino 583275 82.5
polyoxyethylene ether ammonium
dibromide), 5 mg/L fluorescein sodium
Example 15
Referring to the method of Example 1, a chemiluminescent composition was prepared as follows:
2-amino-2-methyl-1-propanol 200 mM
AMPPD 0.5 mM
MgCl
2 5 mM
Compound-1 (dodecylamino polyoxyethylene ether 5 g/L
ammonium dichloride)
Fluorescein Sodium 5 mg/L
Proclin
300 0.5 g/L
pH was adjusted with HCl to 9.5
100 μl of the chemiluminescent composition was added to 50 μl of a 1 ng/mL solution of alkaline phosphatase. Chemiluminescence intensity was measured by a chemiluminescence analyzer, and a chemiluminescent intensity-time curve was plotted. The results are shown in FIG. 1, which demonstrates that the luminescence signal of the chemiluminescent composition of the present disclosure is stable and long lasting.
Example 16 AMPPD+Enhancing Reagent
Referring to the method of Example 1, chemiluminescent composition was formulated with ultra-pure water as follows:
2-amino-2-methyl-1-propanol 200 mM
AMPPD 0.5 mM
MgCl
2 5 mM
Compound 1 (dodecylamino polyoxyethylene ether 5 g/L
ammonium dichloride)
Fluorescein Sodium 5 mg/L
Proclin
300 0.5 g/L
pH was adjusted with HCl to 9.5
100 μl of the chemiluminescent composition was added to 20 μl of a 1 ng/mL solution of alkaline phosphatase. Chemiluminescence intensity was measured by a chemiluminescence analyzer. A commercial chemiluminescent composition, Access Substrate (Beckman), was also measured as a control for comparison. The results are shown in FIG. 2, which demonstrates that the enhancing reagent of the present disclosure enhances the luminescence signal of AMPPD, and that the performance of the chemiluminescent composition is similar to that of Access Substrate (Beckman).
Example 17 CSPD+Enhancing Reagent
Referring to the method of Example 1, a chemiluminescent composition was prepared with ultra-pure water as follows:
2-amino-2-methyl-1-propanol 200 mM
CSPD 0.25 mM
MgCl
2 5 mM
Compound 1 (dodecylamino polyoxyethylene ether 5 g/L
ammonium dichloride)
Fluorescein Sodium 5 mg/L
Proclin
300 0.5 g/L
pH was adjusted with HCl to 9.5
100 μl of the chemiluminescent composition was added to 20 μl of a 1 ng/mL solution of alkaline phosphatase. Chemiluminescence intensity was measured by a chemiluminescence analyzer. A commercial chemiluminescent composition, CSPD & Sapphire-II (Tropix), was also measured as a control for comparison. The results are shown in FIG. 3, which demonstrates that the enhancing reagent of the present disclosure enhances the luminescence signal of CSPD, and that the performance of the chemiluminescent composition is similar to that of CSPD & Sapphire-II (Tropix).
Example 18 CDP-Star+Enhancing Reagent
Referring to the method of Example 1, a chemiluminescent composition was prepared with ultra-pure water as follows:
2-amino-2-methyl-1-propanol 200 mM
CDP-Star 0.25 mM
MgCl
2 5 mM
Compound 1 (dodecylamino polyoxyethylene 5 g/L
ether ammonium dichloride)
Fluorescein Sodium 5 mg/L
Proclin
300 0.5 g/L
pH was adjusted with HCl to 9.5
100 μl of the chemiluminescent composition was added to 20 μl of a 1 ng/mL solution of alkaline phosphatase. Chemiluminescence intensity was measured by a chemiluminescence analyzer. A commercial chemiluminescent composition, CSPD & Sapphire-II (Tropix), was also measured as a control for comparison. The results are shown in FIG. 4, which demonstrates that the enhancing reagent of the present disclosure enhances the luminescence signal of CDP-Star, and that the performance of the chemiluminescent composition is similar to that of CSPD & Sapphire-II (Tropix).
It can be seen from the examples above that alkyl bis-quaternary ammonium salts demonstrate good chemiluminescent enhancing effects for 1,2-dioxetane compounds, as well as an unexpected synergistic enhancing effects in combination with fluorescent agents. Chemiluminescent compositions containing alkyl bis-quaternary ammonium salts can generate strong luminescence signals, thereby improving the detection sensitivity of a diagnosis kit.
The data, figures, instruments, reagents and steps herein should be understood to be illustrative, but not restrictive. Although the present disclosure was described with references to the above concrete embodiments, many modifications and variances will be apparent to skilled persons in the art. All the modifications and variances also fall within the spirit and scope of the disclosure.

Claims (12)

What is claimed is:
1. A method for enhancing the chemiluminescence of 1,2-dioxetane compounds, the method comprising:
providing at least one alkyl bis-quaternary ammonium salt having the structure of General Formula I:
Figure US08563321-20131022-C00007
wherein:
R1 is selected from at least one of the following: C10-20 alkyl, C10-20 alkenyl, C10-20 alkynyl, and C3-8 cycloalkylC6-12 alkyl-;
each n is an integer independently selected from 2 to 15;
each m is an integer independently selected from 1 to 6;
R2, R3, R4, R5, R6, and R7 are each independently selected from at least one of the following: C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, and C3-8 cycloalkyl; and
Xis a negative ion; and
mixing the alkyl bis-quaternary ammonium salt with a 1,2-dioxetane compound.
2. The method of claim 1, wherein R1 is selected from C12-18 alkyl.
3. The method of claim 1, wherein R2, R3, R4, R5, R6, and R7 are each independently selected from methyl or ethyl.
4. The method of claim 1, wherein R2, R3, R4, R5, R6, and R7 are alkyl, each having the same number of carbon atoms.
5. The method of claim 1, wherein each n is an integer independently selected from 5 to 10, or each m is independently selected from 2 or 3.
6. The method of claim 1, wherein Xis selected from at least one of the following: halide ions, ClO4 , PF6 , CF3SO3 , BE4 , acetate, and p-toluene sulfonate anions.
7. The method of claim 1, wherein the alkyl bis-quaternary ammonium salt compound is selected from at least one of the following: dodecylamino polyoxyethylene ether ammonium dichloride, octadecylamino polyoxyethylene ether ammonium dichloride, dodecylamino polyoxyethylene ether ammonium dibromide, octadecylamino polyoxyethylene ether ammonium dibromide, and a combination thereof.
8. The method of claim 1, further comprising dissolving the alkyl bis-quaternary ammonium salt and the 1,2-dioxetane compound in water, wherein the concentration of the alkyl bis-quaternary ammonium salt is in a range of between about 0.1 g/L and about 10 g/L.
9. The method of claim 1, further comprising dissolving the alkyl bis-quaternary ammonium salt and the 1,2-dioxetane compound in water, wherein the concentration of the alkyl bis-quaternary ammonium salt is in a range of between about 1 g/L and about 10 g/L.
10. The method of claim 1, further comprising mixing the alkyl bis-quaternary ammonium salt and the 1,2-dioxetane compound with a fluorescent agent.
11. The method of claim 1, further comprising mixing the alkyl bis-quaternary ammonium salt and the 1,2-dioxetane compound with at least one of: 2-amino-2-methyl-1-propanol or a magnesium ion or both.
12. A method of preparing an enhancing reagent for chemiluminescence of 1,2-dioxetane compounds, comprising:
providing an alkyl bis-quaternary ammonium salt having the structure of General Formula I:
Figure US08563321-20131022-C00008
wherein:
R1 is selected from at least one of the following: C10-20 alkyl, C10-20 alkenyl, C10-20 alkynyl, and C3-8 cycloalkylC6-12 alkyl;
each n is an integer independently selected from 2 to 15;
each m is an integer independently selected from 1 to 6;
R2, R3, R4, R5, R6, and R7 are each independently selected from at least one of the following: C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, and C3-8 cycloalkyl; and
Xis a negative ion;
adding, to purified water, the alkyl bis-quaternary ammonium salt having the structure of General Formula I at a concentration ranging from about 0.1 g/L to about 10 g/L;
adding a 1,2-dioxetane compound at a concentration ranging from about 0.0001 mol/L to about 0.01 mol/L;
optionally adding a fluorescent agent to a concentration ranging from about 0.1 mg/L to about 1 g/L; and
optionally adding magnesium ions to a concentration ranging from about 0.001 mol/L to about 0.01 mol/L and
optionally adding a buffering agent to a concentration ranging from about 10 mM to about 500 mM; and
mixing the added components in the purified water to form an enhancing reagent for chemiluminescence of 1,2-dioxetane compounds.
US13/177,189 2010-07-13 2011-07-06 Chemiluminescent compositions, enhancing reagents for chemiluminescence and methods for the preparation and use thereof Active 2032-02-01 US8563321B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/051,151 US9139766B2 (en) 2010-07-13 2013-10-10 Chemiluminescent compositions and enhancing reagents for chemiluminescence

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201010226676.4 2010-07-13
CN201010226676 2010-07-13
CN201010226676.4A CN102329611B (en) 2010-07-13 2010-07-13 Chemoluminescence enhancing reagent, using method thereof and chemiluminescent liquid

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/051,151 Division US9139766B2 (en) 2010-07-13 2013-10-10 Chemiluminescent compositions and enhancing reagents for chemiluminescence

Publications (2)

Publication Number Publication Date
US20120015446A1 US20120015446A1 (en) 2012-01-19
US8563321B2 true US8563321B2 (en) 2013-10-22

Family

ID=45467300

Family Applications (2)

Application Number Title Priority Date Filing Date
US13/177,189 Active 2032-02-01 US8563321B2 (en) 2010-07-13 2011-07-06 Chemiluminescent compositions, enhancing reagents for chemiluminescence and methods for the preparation and use thereof
US14/051,151 Active 2032-02-06 US9139766B2 (en) 2010-07-13 2013-10-10 Chemiluminescent compositions and enhancing reagents for chemiluminescence

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/051,151 Active 2032-02-06 US9139766B2 (en) 2010-07-13 2013-10-10 Chemiluminescent compositions and enhancing reagents for chemiluminescence

Country Status (2)

Country Link
US (2) US8563321B2 (en)
CN (1) CN102329611B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104597233B (en) 2014-11-05 2016-09-14 深圳市美凯特科技有限公司 Liquid and the method for preparing chemical luminescence for liquid is strengthened for enhanced chemiluminescence
CN104557890A (en) * 2015-01-12 2015-04-29 王国平 Carbon-carbon-oxygen-oxygen four-member ring component and application thereof in mass-spectrometry detection
CN104990912B (en) * 2015-06-26 2018-04-20 江苏浩欧博生物医药股份有限公司 A kind of enzyme-catalyzed chemical luminescence substrate of alkaline phosphatase
FI127861B (en) 2017-06-29 2019-04-15 Labmaster Oy A method and a device for dynamic generation of hot electrons into aqueous solutions
CN110229656A (en) * 2019-08-08 2019-09-13 山东新港化工有限公司 Yin-non-double-hydrophilic surfactant and its preparation method and application
CN116429756A (en) * 2023-04-21 2023-07-14 深圳瑞莱柏生物科技有限公司 Enzymatic chemiluminescent substrate solution of alkaline phosphatase

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857652A (en) 1986-07-17 1989-08-15 Board Of Governors Of Wayne State University Chemiluminescent 1,2-dioxetane compounds
US4959182A (en) 1986-07-17 1990-09-25 Board Of Governors Of Wayne State University Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
US5004565A (en) 1986-07-17 1991-04-02 The Board Of Governors Of Wayne State University Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
US5145772A (en) 1986-07-24 1992-09-08 Tropix, Inc. Chemiluminescence enhancement of enzyme-activated decomposition of enzymatically cleavable chemiluminescent 1,2-dioxetanes
US5393469A (en) 1992-03-20 1995-02-28 Lumigen, Inc. Polymeric phosphonium salts providing enhanced chemiluminescence from 1,2-dioxetanes
US5547836A (en) 1990-08-30 1996-08-20 Tropix, Inc. Enhancement of chemiluminescent assays
US5650099A (en) 1993-06-24 1997-07-22 Lumigen, Inc. Methods and compositions providing enhanced chemiluminescence from chemiluminescent compounds using dicationic surfactants
US20020019553A1 (en) 1995-07-31 2002-02-14 Hashem Akhavan-Tafti Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates
CN1719254A (en) 2005-07-15 2006-01-11 武汉赛文生物技术有限公司 Chemical luminous substrate reinforcing agent
US7091051B2 (en) 2003-08-28 2006-08-15 Tosoh Corporation Chemiluminescence method of 1,2-dioxetane and composition for chemiluminescence
US20090081696A1 (en) 2006-06-08 2009-03-26 Fujirebio Inc. Luminescence enhancer and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4434015B2 (en) * 2002-06-24 2010-03-17 富士レビオ株式会社 Chemiluminescence enhancer
CN102311730B (en) 2010-06-30 2014-09-24 深圳迈瑞生物医疗电子股份有限公司 Chemiluminescence liquid as well as reagent and method enhancing chemiluminescence

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857652A (en) 1986-07-17 1989-08-15 Board Of Governors Of Wayne State University Chemiluminescent 1,2-dioxetane compounds
US4959182A (en) 1986-07-17 1990-09-25 Board Of Governors Of Wayne State University Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
US5004565A (en) 1986-07-17 1991-04-02 The Board Of Governors Of Wayne State University Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
US5145772A (en) 1986-07-24 1992-09-08 Tropix, Inc. Chemiluminescence enhancement of enzyme-activated decomposition of enzymatically cleavable chemiluminescent 1,2-dioxetanes
US5547836A (en) 1990-08-30 1996-08-20 Tropix, Inc. Enhancement of chemiluminescent assays
US5393469A (en) 1992-03-20 1995-02-28 Lumigen, Inc. Polymeric phosphonium salts providing enhanced chemiluminescence from 1,2-dioxetanes
US5650099A (en) 1993-06-24 1997-07-22 Lumigen, Inc. Methods and compositions providing enhanced chemiluminescence from chemiluminescent compounds using dicationic surfactants
US20020019553A1 (en) 1995-07-31 2002-02-14 Hashem Akhavan-Tafti Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates
US7091051B2 (en) 2003-08-28 2006-08-15 Tosoh Corporation Chemiluminescence method of 1,2-dioxetane and composition for chemiluminescence
CN1719254A (en) 2005-07-15 2006-01-11 武汉赛文生物技术有限公司 Chemical luminous substrate reinforcing agent
US20090081696A1 (en) 2006-06-08 2009-03-26 Fujirebio Inc. Luminescence enhancer and use thereof

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
Office Action dated Apr. 10, 2013 for U.S. Appl. No. 13/172,306.
Office Action dated Nov. 2, 2012 for U.S. Appl. No. 13/172,306.
Office Action dated Nov. 6, 2012 for U.S. Appl. No. 13/172,140.
Restriction Requirement dated Aug. 13, 2012 for U.S. Appl. No. 13/172,140.
Schaap et al.. Clinical Chemistry, vol. 35, No. 9, 1989, pp. 1863-1864.
Sha et al., ‘Progress of Research on Chemiluminescene Enzyme Immunoassay’, College of Chemistry, Beijing Normal University, Beijing 100875 China, PTCA (Part B: chem. Anal.) 2010.
Sha et al., 'Progress of Research on Chemiluminescene Enzyme Immunoassay', College of Chemistry, Beijing Normal University, Beijing 100875 China, PTCA (Part B: chem. Anal.) 2010.
U.S. Appl. No. 13/172,140, filed Jun. 29, 2011, Qian et al.
U.S. Appl. No. 13/172,306, filed Jun. 29, 2011, Qian et al.
Waschinski et al., ‘Design of Contact—Active Antimicrobial Acrylate-Based Materials Using Biocidal Macromers.’ Advanced Materials, Wiley Interscience, Advanced Materials 20018, 20, pp. 104-108.
Waschinski et al., 'Design of Contact-Active Antimicrobial Acrylate-Based Materials Using Biocidal Macromers.' Advanced Materials, Wiley Interscience, Advanced Materials 20018, 20, pp. 104-108.

Also Published As

Publication number Publication date
US9139766B2 (en) 2015-09-22
US20120015446A1 (en) 2012-01-19
CN102329611A (en) 2012-01-25
CN102329611B (en) 2015-01-07
US20140103272A1 (en) 2014-04-17

Similar Documents

Publication Publication Date Title
US8557147B2 (en) Chemiluminescent compositions, enhancing reagents for chemiluminescence and methods for the preparation and use thereof
US9139766B2 (en) Chemiluminescent compositions and enhancing reagents for chemiluminescence
WO2016206654A2 (en) Alkaline phosphatase enzymatic chemiluminescent substrate
US8883514B2 (en) Chemiluminescent compositions, enhancing reagents for chemiluminescence and methods for the preparation and use thereof
CN112067601B (en) Alkaline phosphate enzymatic chemiluminescence substrate reinforcing agent and application thereof
EP1120652A1 (en) Enhancement of chemiluminescence in assays
CN102435598A (en) Stable HRP enzymatic enhanced chemiluminescent substrate solution
US6767716B2 (en) Chemluminescent systems containing unsaturated 1,2-dioxetanes
JP4259229B2 (en) Method for chemiluminescence of 1,2-dioxetane and composition for chemiluminescence
US6852503B1 (en) Compositions and methods for utilizing mixed substrate solutions of luminols and dioxetanes
US10073039B2 (en) Degradable cationic surfactants and use thereof in enhancing chemiluminescence
JPH05140146A (en) Stabilizing agent of 1,2-dioxetane derivative
JP3792908B2 (en) Method for measuring peroxidase activity
JP3792898B2 (en) Method for measuring peroxidase activity
JP4286356B2 (en) Method for measuring peroxidase activity
JP3792885B2 (en) Method for measuring peroxidase activity
JP3720988B2 (en) Novel chemiluminescent reagent and method for producing the same
JP3792897B2 (en) Novel chemiluminescent reagent and method for producing the same
JP3996283B2 (en) Method for producing a new chemiluminescent reagent
JP3745113B2 (en) Method for measuring peroxidase activity
JP2014141642A (en) Chemoluminescence method for 1,2-dioxetane and material for chemoluminescence
JP2001181291A (en) Stabilizer for 1,2-dioxetane derivative
CA2350808A1 (en) Chemiluminescent substrates for neuraminidase, assays for detection of neuraminidase and kits therefor
JPH11279549A (en) Chemiluminescent reagent and its production
JPH11221097A (en) Measurement of peroxidase activity

Legal Events

Date Code Title Description
AS Assignment

Owner name: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:QIAN, CHUNGEN;ZHANG, YUPING;REEL/FRAME:026549/0987

Effective date: 20110703

STCF Information on status: patent grant

Free format text: PATENTED CASE

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 8

AS Assignment

Owner name: SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD., CHINA

Free format text: LICENSE;ASSIGNOR:SHENZHEN MINDRAY BIOMEDICAL ELECTRONICS CO., LTD.;REEL/FRAME:060440/0796

Effective date: 20220601